Aprio Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
41,748
-2,042
-5% -$53.4K 0.05% 234
2026
Q1
$1.23M Buy
43,790
+9,514
+28% +$253K 0.07% 169
2025
Q4
$1.17M Buy
34,276
+11,602
+51% +$293K 0.07% 174
2025
Q3
$578K Buy
22,674
+5,565
+33% +$137K 0.06% 197
2025
Q2
$415K Sell
17,109
-3,584
-17% -$83.6K 0.05% 224
2025
Q1
$524K Buy
20,693
+4,316
+26% +$113K 0.07% 174
2024
Q4
$434K Buy
16,377
+281
+2% +$7.62K 0.06% 149
2024
Q3
$466K Sell
16,096
-35,068
-69% -$1.02M 0.07% 130
2024
Q2
$1.43M Buy
51,164
+8,643
+20% +$238K 0.26% 50
2024
Q1
$1.18M Buy
42,521
+2,857
+7% +$79.3K 0.23% 54
2023
Q4
$1.14M Sell
39,664
-1,493
-4% -$45.1K 0.25% 49
2023
Q3
$1.37M Sell
41,157
-1,022
-2% -$36.1K 0.38% 39
2023
Q2
$1.55M Buy
42,179
+34,662
+461% +$1.35M 0.42% 31
2023
Q1
$307K Buy
7,517
+1,082
+17% +$46.7K 0.09% 96
2022
Q4
$330K Buy
6,435
+270
+4% +$12.9K 0.12% 83
2022
Q3
$270K Sell
6,165
-1,057
-15% -$51.4K 0.11% 83
2022
Q2
$379K Buy
7,222
+222
+3% +$11.3K 0.15% 57
2022
Q1
$362K Buy
7,000
+3,124
+81% +$162K 0.14% 60
2021
Q4
$229K Buy
+3,876
New +$192K 0.1% 65
2021
Q3
Sell
-5,194
Closed -$203K 75
2021
Q2
$203K Buy
+5,194
New +$202K 0.1% 69
2020
Q4
$269K Sell
7,312
-1,008
-12% -$37K 0.18% 42
2020
Q3
$290K Buy
8,320
+32
+0.4% +$1.12K 0.21% 53
2020
Q2
$257K Sell
8,288
-58
-0.7% -$1.97K 0.25% 52
2020
Q1
$258K Buy
8,346
+1,668
+25% +$56.8K 0.33% 46
2019
Q4
$248K Buy
+6,678
New +$238K 0.18% 60

Other funds holding PFE

Aprio Wealth Management's PFE Position: Q2 2026 in Review

Aprio Wealth Management reduced its Pfizer (PFE) stake by 4.7% in Q2 2026, selling an estimated $53.4K and leaving 41,748 shares worth $1.01M. The position accounts for 0.05% of the portfolio, ranked #234.

Aprio Wealth Management first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.55M in Q2 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Aprio Wealth Management held 41,748 shares of Pfizer worth $1.01M as of Q2 2026.
  • Aprio Wealth Management sold 2,042 Pfizer shares in Q2 2026, an estimated $53.4K.
  • Pfizer made up 0.05% of Aprio Wealth Management's portfolio in Q2 2026, its #234 holding.
  • Aprio Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
  • Aprio Wealth Management's Pfizer position peaked at $1.55M in Q2 2023.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.